Bausch Health (MEX:BHCN) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)


MEX:BHCN Bausch Health Companies Inc MEX:BHCN
48 GF Score
Price MXN85.44
GF Value MXN188.23
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health ROE % Adjusted to Book Value?

Bausch Health MEX:BHCN 48 ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus rates MEX:BHCN with a GF Score™ of 48/100 and a GF Value™ of MXN188.23 (Possible Value Trap). The stock has 3 warning signs investors should review.

Bausch Health's ROE % for the quarter that ended in Mar. 2026 was 0.00%. Bausch Health's PB Ratio for the quarter that ended in Mar. 2026 was N/A. Bausch Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.

Bausch Health ROE % Adjusted to Book Value Related Terms

Bausch Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Bausch Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health ROE % Adjusted to Book Value Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 Negative Equity

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 Negative Equity Negative Equity 0.00 0.00

MEX:BHCN vs ZTS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bausch Health's ROE % Adjusted to Book Value falls into.


MEX:BHCN
48GF Score
Bausch Health Companies Inc MEX:BHCN
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health ROE % Adjusted to Book Value Calculation

Bausch Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

Bausch Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Bausch Health (MEX:BHCN) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bausch Health and its competitors.
Is Bausch Health's ROE % Adjusted to Book Value too high?
Bausch Health's current ROE % Adjusted to Book Value is 0.00%. Overall, Bausch Health has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's ROE % Adjusted to Book Value compare to ZTS?
Bausch Health's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bausch Health and its competitors. Bausch Health's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN188.23, compared to a current price of MXN85.44 — trading 54.6% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Bausch Health's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (MEX:BHCN) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of MXN85.44 is trading 54.6% below its estimated GF Value™ of MXN188.23. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for MEX:BHCN:

  • ROE % Adjusted to Book Value: 0.00%
  • GF Value™: MXN188.23 vs. price of MXN85.44 (54.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
48GF Score

Get the complete analysis for MEX:BHCN

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.44
Price
MXN188.23
GF Value